UY35706A - Vacuna contra nematodos de ovinos - Google Patents

Vacuna contra nematodos de ovinos

Info

Publication number
UY35706A
UY35706A UY0001035706A UY35706A UY35706A UY 35706 A UY35706 A UY 35706A UY 0001035706 A UY0001035706 A UY 0001035706A UY 35706 A UY35706 A UY 35706A UY 35706 A UY35706 A UY 35706A
Authority
UY
Uruguay
Prior art keywords
teladorsagia
immune responses
animals
sheep
vaccine against
Prior art date
Application number
UY0001035706A
Other languages
English (en)
Inventor
Alasdair Justice Nisbet
Knox David
Matthews Jacqueline
Original Assignee
Moredun Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moredun Res Inst filed Critical Moredun Res Inst
Publication of UY35706A publication Critical patent/UY35706A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se basa en la identificación de un grupo de antígenos derivados de especies del género Teladorsagia, los cuales pueden utilizarse para generar respuestas inmunes en animales —en particular aquellos animales que muestran susceptibilidad o predisposición a la infección por o infestación con una o más especies de Teladorsagia. Los antígenos pueden ser utilizados para dar lugar a composiciones y vacunas para generar respuestas inmunes protectoras en animales, donde las respuestas inmunes protectoras sirven para disminuir, prevenir, tratar o eliminar las infecciones o infestaciones de Teladorsagia.
UY0001035706A 2012-02-07 2014-08-14 Vacuna contra nematodos de ovinos UY35706A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1202090.5A GB201202090D0 (en) 2012-02-07 2012-02-07 Vaccine
PCT/GB2013/050247 WO2013117912A1 (en) 2012-02-07 2013-02-04 Sheep nematode vaccine

Publications (1)

Publication Number Publication Date
UY35706A true UY35706A (es) 2016-02-29

Family

ID=45896736

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035706A UY35706A (es) 2012-02-07 2014-08-14 Vacuna contra nematodos de ovinos

Country Status (9)

Country Link
US (2) US9717780B2 (es)
EP (2) EP2812023B1 (es)
AU (2) AU2013217398B2 (es)
BR (1) BR112014019293A2 (es)
ES (1) ES2688302T3 (es)
GB (1) GB201202090D0 (es)
NZ (1) NZ629420A (es)
UY (1) UY35706A (es)
WO (1) WO2013117912A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021161472A1 (ja) * 2020-02-13 2021-08-19 株式会社Ｎｔｔドコモ 端末、無線通信方法及び基地局

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2172492A1 (en) * 1993-09-28 1995-04-06 Elza Nicole Theresia Meeusen Protective antigens against parasites

Also Published As

Publication number Publication date
NZ723022A (en) 2021-04-30
BR112014019293A2 (pt) 2017-07-11
US9717780B2 (en) 2017-08-01
AU2018201329B2 (en) 2019-11-14
NZ629420A (en) 2016-12-23
EP2812023B1 (en) 2018-08-01
GB201202090D0 (en) 2012-03-21
EP2812023A1 (en) 2014-12-17
US20150040251A1 (en) 2015-02-05
AU2013217398B2 (en) 2018-03-15
AU2013217398A1 (en) 2014-09-18
EP3456345A1 (en) 2019-03-20
US20180008685A1 (en) 2018-01-11
AU2018201329A1 (en) 2018-03-15
WO2013117912A1 (en) 2013-08-15
US10117914B2 (en) 2018-11-06
ES2688302T3 (es) 2018-10-31

Similar Documents

Publication Publication Date Title
EA201800108A1 (ru) Вакцинные композиции для профилактики абровирусных инфекций
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
BR112018008901A8 (pt) formulações subcutâneas de anticorpos anti-cd 38 e seus usos
EA201591761A1 (ru) Композиции на основе наночастиц
BR112017001796A2 (pt) composições de flagelina e seus usos
DOP2015000098A (es) Terapia adyuvante con inhibidores de quinasa de la familia tec
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
BR112019004785A2 (pt) variantes de alfa-glicosidase ácida e usos das mesmas
AR089797A1 (es) Vacunas contra clostridum difficile que comprenden toxinas recombinantes
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
AR091316A1 (es) Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos
CL2019000610A1 (es) Variantes de alfa-glucosidasa ácida y usos de las mismas.
AR091582A1 (es) Vacunas atenuadas contra streptococcus suis y metodos de elaboracion y uso de las mismas
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
EA201790517A1 (ru) Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции
BR112018002382A2 (pt) novos anticorpos anti-gvpi humano e usos dos mesmos
MX2017005687A (es) Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia.
ECSP19008417A (es) Anticuerpos con inmunogenicidad baja y usos de estos
BR112018015893A2 (pt) vacinas de câncer e métodos de tratamento usando as mesmas
PE20181158A1 (es) Vacunacion con el dominio alfa 3 de mica/b para el tratamiento del cancer
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
BR112017025316A2 (pt) estratégia de vacina baseada em nanopartículas contra o vírus da gripe suína
CL2018000253A1 (es) Respuesta inmunitaria potenciada de las especies porcinas
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
GB201112587D0 (en) Vaccine

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20230821